← USPTO Patent Grants

MCT formulations for improving cognitive functions

Grant US12582627B2 Kind: B2 Mar 24, 2026

Assignee

SOCIETE DES PRODUITS NESTLE S.A.

Inventors

Bernard Cuenoud, Stephen Cosgrave Cunnane

Abstract

Methods improve cognitive functioning, for example, at least one of episodic memory, executive function, or language skills; supporting memory and/or recall; providing energy and/or ketones to the brain; and/or preventing and/or treating mild cognitive impairment (MCI) in an individual. A composition comprising medium chain triglycerides (MCTs) can be administered to the individual in a daily dosage providing from about 15 g to about 45 g MCTs. The MCTs can include from about 51 wt % to about 90 wt % of octanoic acid. The daily dose can be provided in at least two servings, for example, 2 or 3 servings. Each serving can provide about 15 g MCTs and can include octanoic acid and decanoic acid in a weight ratio of, for example, about 60:about 40. The individual can be 65 years or older and/or have mild cognitive impairment (MCI).

CPC Classifications

A61K 31/225 A61K 31/23 A61P 9/10 A61P 9/00 A23L 33/12 A23L 2/52

Filing Date

2021-05-17

Application No.

17998891

Claims

12